Boston Mountain Money Management Inc. Sells 53 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Boston Mountain Money Management Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,178 shares of the healthcare conglomerate’s stock after selling 53 shares during the period. UnitedHealth Group makes up about 0.4% of Boston Mountain Money Management Inc.’s investment portfolio, making the stock its 28th largest holding. Boston Mountain Money Management Inc.’s holdings in UnitedHealth Group were worth $689,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the company. Empirical Asset Management LLC grew its position in UnitedHealth Group by 0.5% in the 3rd quarter. Empirical Asset Management LLC now owns 18,699 shares of the healthcare conglomerate’s stock worth $10,933,000 after purchasing an additional 87 shares during the period. Adamsbrown Wealth Consultants LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $228,000. Cherrydale Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 4.9% in the 3rd quarter. Cherrydale Wealth Management LLC now owns 820 shares of the healthcare conglomerate’s stock worth $479,000 after purchasing an additional 38 shares during the period. Stablepoint Partners LLC increased its holdings in UnitedHealth Group by 1.0% during the third quarter. Stablepoint Partners LLC now owns 5,455 shares of the healthcare conglomerate’s stock valued at $3,189,000 after buying an additional 54 shares during the last quarter. Finally, ORG Wealth Partners LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth $454,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.4 %

NYSE UNH traded up $2.50 during trading on Monday, reaching $600.55. 370,673 shares of the company’s stock traded hands, compared to its average volume of 3,903,210. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The company’s 50 day simple moving average is $583.64 and its two-hundred day simple moving average is $531.35. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The firm has a market cap of $554.56 billion, a price-to-earnings ratio of 39.66, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company posted $6.14 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio (DPR) is 55.70%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on UNH. HSBC boosted their price objective on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Barclays increased their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 1st. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $617.37.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.